BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20403333)

  • 1. Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.
    Mundt HM; Stremmel W; Melino G; Krammer PH; Schilling T; Müller M
    Biochem Biophys Res Commun; 2010 May; 396(2):335-41. PubMed ID: 20403333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
    Schuster A; Schilling T; De Laurenzi V; Koch AF; Seitz S; Staib F; Teufel A; Thorgeirsson SS; Galle P; Melino G; Stremmel W; Krammer PH; Müller M
    Cell Cycle; 2010 Jul; 9(13):2629-39. PubMed ID: 20581467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria.
    Gressner O; Schilling T; Lorenz K; Schulze Schleithoff E; Koch A; Schulze-Bergkamen H; Lena AM; Candi E; Terrinoni A; Catani MV; Oren M; Melino G; Krammer PH; Stremmel W; Müller M
    EMBO J; 2005 Jul; 24(13):2458-71. PubMed ID: 15944736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
    Schilling T; Kairat A; Melino G; Krammer PH; Stremmel W; Oren M; Müller M
    Biochem Biophys Res Commun; 2010 Apr; 394(3):817-23. PubMed ID: 20233581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).
    Sun R; Zhang Y; Lv Q; Liu B; Jin M; Zhang W; He Q; Deng M; Liu X; Li G; Li Y; Zhou G; Xie P; Xie X; Hu J; Duan Z
    J Biol Chem; 2011 May; 286(18):15918-28. PubMed ID: 21367858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
    Helton ES; Zhu J; Chen X
    J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta.
    Chatterjee A; Chang X; Sen T; Ravi R; Bedi A; Sidransky D
    Cancer Res; 2010 Feb; 70(4):1419-29. PubMed ID: 20145131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis.
    Sayan BS; Sayan AE; Yang AL; Aqeilan RI; Candi E; Cohen GM; Knight RA; Croce CM; Melino G
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10871-6. PubMed ID: 17581882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
    Komatsu S; Takenobu H; Ozaki T; Ando K; Koida N; Suenaga Y; Ichikawa T; Hishiki T; Chiba T; Iwama A; Yoshida H; Ohnuma N; Nakagawara A; Kamijo T
    Oncogene; 2009 Oct; 28(41):3631-41. PubMed ID: 19668228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis.
    King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC
    Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
    Danilov AV; Neupane D; Nagaraja AS; Feofanova EV; Humphries LA; DiRenzo J; Korc M
    PLoS One; 2011; 6(10):e26815. PubMed ID: 22053213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway.
    Seitz SJ; Schleithoff ES; Koch A; Schuster A; Teufel A; Staib F; Stremmel W; Melino G; Krammer PH; Schilling T; Müller M
    Int J Cancer; 2010 May; 126(9):2049-66. PubMed ID: 19711344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
    González R; De la Rosa ÁJ; Rufini A; Rodríguez-Hernández MA; Navarro-Villarán E; Marchal T; Pereira S; De la Mata M; Müller-Schilling M; Pascasio-Acevedo JM; Ferrer-Ríos MT; Gómez-Bravo MA; Padillo FJ; Muntané J
    PLoS One; 2017; 12(3):e0174326. PubMed ID: 28350813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
    Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
    Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.
    Leong CO; Vidnovic N; DeYoung MP; Sgroi D; Ellisen LW
    J Clin Invest; 2007 May; 117(5):1370-80. PubMed ID: 17446929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
    Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW
    Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.